Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Retrospective Study to Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT07013760 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07013760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Retrospective Study to Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 23, 2025
Completion date
December 19, 2025
Enrollment
420 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

asthma